SkinHealth Systems Inc. - Class A Common Stock (SKIN)
1.0500
-0.0600 (-5.41%)
NASDAQ· Last Trade: Jul 8th, 6:08 PM EDT
Detailed Quote
Previous Close
1.110
Open
1.100
Bid
1.010
Ask
1.040
Day's Range
0.9811 - 1.220
52 Week Range
0.5506 - 2.690
Volume
6,825,434
Market Cap
158.13M
PE Ratio (TTM)
-5.526
EPS (TTM)
-0.2
Dividend & Yield
N/A (N/A)
1 Month Average Volume
5,692,003
Chart
About SkinHealth Systems Inc. - Class A Common Stock (SKIN)
The Beauty Health Co. is a dynamic company specializing in innovative skincare solutions and aesthetic technologies. Focused on enhancing beauty and wellness, the company develops and markets unique products and treatment systems that cater to both professional and consumer markets. By leveraging advanced science and cutting-edge techniques, The Beauty Health Co. aims to address various skincare needs, promoting healthier skin and boosting confidence among its users. The company's commitment to quality and innovation positions it as a leader in the rapidly evolving beauty industry. Read More
An advanced, non-invasive scalp treatment with no downtime, featuring newly engineered tips and clinically proven to visibly improve scalp health and the appearance of fuller, thicker-looking hair
Beauty Health (NASDAQ:SKIN), referred to by executives as SkinHealth Systems following a recent rebrand, reported first-quarter 2026 net sales of $64.9 million, down 6.7% from the prior year, as weaker device placements continued to weigh on growth. The company said adjusted EBITDA rose 17% year ove
LONG BEACH, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN) (“SkinHealth Systems” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2026 (“Q1 2026”).
LONG BEACH, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (formerly The Beauty Health Company; Nasdaq: SKIN), a global medical aesthetics company, today announced it will report first quarter 2026 financial results after market close on Thursday, May 7, 2026. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results.
LONG BEACH, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the full year and fourth quarter ended December 31, 2025 (“Q4 2025”).
The Hydrafacial Treatment and SkinStylus Nano-Channeling Protocol Addresses Rising Consumer Demand for Combination Treatments That Can Improve Performance and Enhance Results
LONG BEACH, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report fourth quarter and full year 2025 financial results after market close on Thursday, March 12, 2026. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results.
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential.
However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south.
While some investors embrace risk, mistakes can be costly for those who aren’t prepared.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how personal care stocks fared in Q3, starting with Nature's Sunshine (NASDAQ:NATR).
Unprofitable companies face headwinds as they struggle to keep operating expenses under control.
Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.
But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
